Milk and plasma concentrations of the progestin ST-1435 in women treated parenterally with ST-1435
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 42 (5) , 555-562
- https://doi.org/10.1016/0010-7824(90)90082-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Concentration-dependent mechanisms of ovulation inhibition by the progestin ST-1435Fertility and Sterility, 1985
- Contraception with subdermal ST-1435 capsules: Side-effects, endocrine profiles and liver function related to different lengths of capsulesContraception, 1985
- Intestinal absorption of ST-1435 in ratsContraception, 1984
- Intracervical release of ST-1435 for contraceptionContraception, 1984
- Serum non-protein bound percentage and distribution of the progestin ST-1435: no effect of ST-1435 treatment on plasma SHBG and CBG binding capacitiesActa Endocrinologica, 1983
- Transfer of contraceptive steroids in milk of women using long-acting gestagensContraception, 1982
- Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUDContraception, 1982
- Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435Contraception, 1981
- d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing womenAmerican Journal of Obstetrics and Gynecology, 1977
- Column Chromatography of Steroids on Sephadex LH-20Journal of Clinical Endocrinology & Metabolism, 1971